NewCo News: Calibrant Seeking Corporate Partner as It Looks to Future May 2, 2008 By Catherine Hollingsworth
Second Strike on Rituxan as it Fails in Lupus Trial April 30, 2008 By Catherine Hollingsworth Still reeling from a negative study of Rituxan in multiple sclerosis patients, Genentech Inc. and Biogen Idec Inc. reported more unfavorable data Tuesday from a Phase II/III study of the drug in lupus patients. (BioWorld Today)Read More
